These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 912840)

  • 1. Infarct size reduction by propranolol before and after coronary ligation in dogs.
    Rasmussen MM; Reimer KA; Kloner RA; Jennings RB
    Circulation; 1977 Nov; 56(5):794-8. PubMed ID: 912840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.
    Reimer KA; Lowe JE; Rasmussen MM; Jennings RB
    Circulation; 1977 Nov; 56(5):786-94. PubMed ID: 912839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.
    Reimer KA; Jennings RB
    Lab Invest; 1979 Jun; 40(6):633-44. PubMed ID: 449273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs.
    Reimer KA; Rasmussen MM; Jennings RB
    Am J Cardiol; 1976 Mar; 37(4):520-7. PubMed ID: 1258789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of propranolol, timolol and metoprolol on myocardial infarct size after experimental coronary artery occlusion.
    Vik-Mo H; Maroko PR; Ribeiro LG
    J Am Coll Cardiol; 1984 Oct; 4(4):735-41. PubMed ID: 6481013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction.
    Reimer KA; Jennings RB
    Am J Cardiol; 1985 Jan; 55(3):107B-115B. PubMed ID: 3881903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of propranolol on infarct size and the impaired hemodynamics in experimental myocardial infarcted dogs.
    Tsuchida K; Yamazaki R; Kaneko K; Kimura M; Aihara H
    J Pharmacobiodyn; 1985 Nov; 8(11):964-8. PubMed ID: 4093850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs.
    Reimer KA; Rasmussen MM; Jennings RB
    Circ Res; 1973 Sep; 33(3):353-63. PubMed ID: 4746723
    [No Abstract]   [Full Text] [Related]  

  • 10. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infarct-sparing effect of propranolol in an occlusion-reperfusion dog model.
    Chagas AC; Da-Luz PL; Pileggi F
    Braz J Med Biol Res; 1989; 22(11):1337-45. PubMed ID: 2638925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of myocardial infarct volume. An experimental study in the dog.
    Pierce WS; Carter DR; McGavran MH; Waldhausen JA
    Arch Surg; 1973 Nov; 107(5):682-7. PubMed ID: 4126701
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion.
    Maroko PR; Libby P; Sobel BE; Bloor CM; Sybers HD; Shell WE; Covell JW; Braunwald E
    Circulation; 1972 Jun; 45(6):1160-75. PubMed ID: 5032816
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of lidocaine and pyromecaine on the size of an experimental myocardial infarct].
    Goldshteĭne GKh; Tsorin IB; Chichkanov GG
    Biull Eksp Biol Med; 1986 Feb; 101(2):177-9. PubMed ID: 3947734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental infarct size as a function of the amount of myocardium at risk.
    Lowe JE; Reimer KA; Jennings RB
    Am J Pathol; 1978 Feb; 90(2):363-79. PubMed ID: 623206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial infarction in the dog: effects of intravenous propranolol.
    Fox K; Welman E; Selwyn A
    Am J Cardiol; 1980 Apr; 45(4):769-74. PubMed ID: 7361667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inability of isoproterenol or propranolol to alter the lateral dimensions of experimentally induced myocardial infarcts.
    Downey JM; Chambers D; Wilkerson RD
    Basic Res Cardiol; 1982; 77(5):486-98. PubMed ID: 7181829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of infarct size limitation by propranolol on ventricular arrhythmias after myocardial infarction.
    Stewart JR; Gibson JK; Lucchesi BR
    Ann N Y Acad Sci; 1982; 382():223-8. PubMed ID: 7044241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of ischemic myocardium: comparison of effects of propranolol, bevantolol and N-dimethyl propranolol on infarct size following coronary artery occlusion in anesthetized dogs.
    Warltier DC; Gross GJ; Jesmok GJ; Brooks HL; Hardman HF
    Cardiology; 1980; 66(3):133-46. PubMed ID: 6105914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of allopurinol, propranolol and methylprednisolone on infarct size in experimental myocardial infarction.
    Shatney CH; MacCarter DJ; Lillehei RC
    Am J Cardiol; 1976 Mar; 37(4):572-80. PubMed ID: 3960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.